As the popular science news portal Videnskab.dk has reported, course organizers in the life sciences are to be urged to stop using animals in their courses. This would mean a saving of around 700-800 animals a year.
According to the non-governmental organization Humane Society International, the Brazilian Senate has passed a new law on chemical management that limits animal testing to a last resort and requires the development of a strategic plan for the complete elimination of animal testing. The law still has to be approved by the Brazilian President.
The Ministry of Science, Research and the Arts is funding three additional 3R centers in Baden-Württemberg. The new institutions will primarily develop digital and AI-supported approaches. The Ministry is providing 750,000 euros over the next three years for this purpose.
Nephropathologists Birgit Helmchen and Ariana Gaspert, molecular biologist Anne-Laure Leblond and other researchers from France and Switzerland have discovered how a hepatitis E virus infection can also damage the kidneys by examining tissue samples from infected individuals.
The University of Windsor has officially closed the Canadian Centre for Alternatives to Animal Methods (CCAAM). The reason given is budgetary constraints. CCAAM is now dependent on financial aid. The closure is in clear contradiction to Bill S-5 of June 2023 - a law that aims, among other things, to reduce and replace the use of vertebrate animals in toxicity testing of chemicals.
The Malaysian biotechnology group Biogenes Technologies launches the world's first aptamer-based histochemistry staining product developed using its proprietary biocomputational platform APTCAD.com. The product offers users with animal-free option to antibodies that are extracted from animals.
Together with scientists from the University of Central Florida, Hesperos Inc. in Orlando has developed a model of peripheral myelination derived from human induced pluripotent stem cells. It enables research into therapies for currently incurable diseases of the peripheral nervous system, such as Charcot-Marie-Tooth disease or Guillain-Barré syndrome.
On October 25, the European Commission hosted the second conference on the roadmap for phasing out animal testing in the safety assessment of chemicals. The focus was on bringing order to the objectives, accelerating recognition and securing funding.
VICT3R (Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research) is a public-private partnership funded by the European Innovative Health Initiative (IHI). The aim is to reduce animal use in toxicology research, improve scientific results and maintain higher ethical standards.
Researchers at the Berlin Institute of Health (BIH) have received funding form European Research Council (ERC). For their studies, they are using human induced pluripotent stem cells.